CLX Clorox
Intrinsic value$37.15
Price (at call)$83.10
Margin of safety
-55.3%
vs market (rating basis)
-7.2%
Model unavailable; showing baseline valuation.
⚠ LLM error: empty response; using baseline
The story
Value drivers
| Revenue growth (Y1) | -3.1% |
| Terminal growth | 3.5% |
| Forecast horizon | 10y |
| Target operating margin | 13.7% |
| Years to target margin | 5 |
| Sales-to-capital | 1.30 |
| Beta | 0.54 |
| Failure probability | 0.0% |
| Cost of capital (WACC) | 7.3% |
| Terminal WACC | 8.7% |
Valuation bridge
| PV of explicit FCFF | 4.33B |
| PV of terminal value | 5.25B |
| Equity value | 4.49B |
| ÷ shares → per share | $37.15 |
News
neutral -0.10 · 8 articles
- These 6 Massive Dividend Yields May Be Too Good to Be True
- 3 Consumer Stocks We Keep Off Our Radar
- ADRNY vs. CLX: Which Stock Should Value Investors Buy Now?
- Will Strategic Initiatives and Pricing Strength Boost Clorox's Growth?
- Is Clorox (CLX) Reasonably Priced on Its Earnings Today?
- Procter & Gamble Stock Looks Pricey: What's the Best Move Now?
- 15 of the Highest-Yielding Dividend Stocks in the S&P 500
- Passive Income Investors Are Buying 5 Well-Known High-Yield Stocks Near 52-Week Lows
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 6.51B | -3.1% | 13.7% | 677.98M | 0 | 677.98M | 631.93M |
| 2 | 6.36B | -2.4% | 13.7% | 661.85M | 0 | 661.85M | 575.00M |
| 3 | 6.25B | -1.6% | 13.7% | 650.97M | 0 | 650.97M | 527.13M |
| 4 | 6.19B | -0.9% | 13.7% | 645.05M | 0 | 645.05M | 486.86M |
| 5 | 6.18B | -0.2% | 13.7% | 643.93M | 0 | 643.93M | 453.00M |
| 6 | 6.22B | 0.6% | 13.7% | 647.54M | 26.60M | 620.93M | 407.16M |
| 7 | 6.30B | 1.3% | 13.7% | 655.92M | 61.83M | 594.10M | 363.10M |
| 8 | 6.43B | 2.0% | 13.7% | 669.24M | 98.16M | 571.08M | 325.33M |
| 9 | 6.60B | 2.8% | 13.7% | 687.75M | 136.40M | 551.34M | 292.75M |
| 10 | 6.84B | 3.5% | 13.7% | 711.82M | 177.43M | 534.39M | 264.48M |